Sun Starts Integration Of GSK's Opiates Business
Sun Pharmaceutical Industries has started the integration of its opiates business in Australia, acquired earlier this year from GlaxoSmithKline, following the completion of the deal.
Sun Pharmaceutical Industries has started the integration of its opiates business in Australia, acquired earlier this year from GlaxoSmithKline, following the completion of the deal.